Abstract

Burkholderia cenocepacia is an emerging opportunistic pathogen for people with cystic fibrosis and chronic granulomatous disease. Intracellular survival in macrophages within a membrane-bound vacuole (BcCV) that delays acidification and maturation into lysosomes is a hallmark of B. cenocepacia infection. Intracellular B. cenocepacia induce an inflammatory response leading to macrophage cell death by pyroptosis through the secretion of a bacterial deamidase that results in the activation of the pyrin inflammasome. However, how or whether infected macrophages can process and present B. cenocepacia antigens to activate T-cells has not been explored. Engulfed bacterial protein antigens are cleaved into small peptides in the late endosomal major histocompatibility class II complex (MHC) compartment (MIIC). Here, we demonstrate that BcCVs and MIICs have overlapping features and that interferon-gamma-activated macrophages infected with B. cenocepacia can process bacterial antigens for presentation by class II MHC molecules to CD4+ T-cells and by class I MHC molecules to CD8+ T-cells. Infected macrophages also release processed bacterial peptides into the extracellular medium, stabilizing empty class I MHC molecules of bystander cells. Together, we conclude that BcCVs acquire MIIC characteristics, supporting the notion that macrophages infected with B. cenocepacia contribute to establishing an adaptive immune response against the pathogen.

Details

Title
Interferon-gamma-activated macrophages infected with Burkholderia cenocepacia process and present bacterial antigens to T-cells by class I and II major histocompatibility complex molecules
Author
Rosales-Reyes, Roberto 1   VIAFID ORCID Logo  ; Garza-Villafuerte, Paola 1   VIAFID ORCID Logo  ; Vences-Vences, Daniela 1   VIAFID ORCID Logo  ; Aubert, Daniel F 2   VIAFID ORCID Logo  ; Aca-Teutle, Rubi 1   VIAFID ORCID Logo  ; Ortiz-Navarrete, Vianney F 3   VIAFID ORCID Logo  ; Bonifaz, Laura C 4   VIAFID ORCID Logo  ; Carrero-Sánchez, Julio Cesar 5   VIAFID ORCID Logo  ; Olivos-García, Alfonso 1   VIAFID ORCID Logo  ; Valvano, Miguel A 6   VIAFID ORCID Logo  ; Santos-Preciado, José Ignacio 1   VIAFID ORCID Logo 

 Facultad de Medicina, Unidad de Investigación en Medicina Experimental, Universidad Nacional Autónoma de México, Mexico City, México 
 Department of Microbiology and Immunology, The University of Western Ontario, London, Canada 
 Departamento de Biomedicina Molecular, Centro de Investigación y de Estudios Avanzados del IPN, Mexico City, México 
 Unidad de Investigación Médica en Inmunoquímica Hospital de Especialidades Centro Médico Nacional Siglo XXI, IMSS, Mexico City, Mexico 
 Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Mexico City, Mexico 
 Department of Microbiology and Immunology, The University of Western Ontario, London, Canada; The Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK 
Pages
2000-2012
Publication year
2020
Publication date
Dec 2020
Publisher
Taylor & Francis Ltd.
e-ISSN
22221751
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2508721458
Copyright
© 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.